Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Loretta J. Nastoupil"'
Autor:
Jonathon B. Cohen, Daniel M Guidot, Joseph Maly, Jeffrey M. Switchenko, Loretta J. Nastoupil, Jean L. Koff, Christopher R. Flowers, Kristie A. Blum
Publikováno v:
Leukemia & Lymphoma. 59:888-895
Mantle cell lymphoma (MCL) is a heterogeneous disease with high relapse rates. Limited data guide the use of surveillance imaging following treatment. We constructed a retrospective cohort from two academic institutions of patients with MCL who compl
Autor:
Loretta J. Nastoupil, Christopher R. Flowers, Jessica N. Williams, Jean L. Koff, Ashish Rai, Joseph Lipscomb
Publikováno v:
Cancer. 121:1800-1808
BACKGROUND Although the combination of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is considered standard therapy for diffuse large B-cell lymphoma (DLBCL), patterns of use and the impact of R-CHOP on survival in pa
Autor:
Kun Jiang, Xiaojing Wang, Satya Das, Mohammad K. Khan, Christopher R. Flowers, Zheng Shi, Natia Esiashvili, Zhengjia Chen, Derick Okwan-Duodu, Loretta J. Nastoupil
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 86:569-577
The role of consolidative radiation therapy (RT) after complete response (CR) to rituximab combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for stage III-IV diffuse large B-cell lymphoma (DLBCL) patients is unclear. W
Autor:
Jessica N. Williams, Jean L. Koff, Loretta J. Nastoupil, Joseph Lipscomb, Ashish Rai, Christopher R. Flowers
Context: Despite having the highest incidence of diffuse large B-cell lymphoma (DLBCL), individuals older than 80 years are rarely included in DLBCL clinical trials or epidemiological studies. We sought to better characterize DLBCL presentation, trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fee4424f0ed48669cd5b02edd51ac83
https://europepmc.org/articles/PMC4441579/
https://europepmc.org/articles/PMC4441579/
Autor:
Loretta J. Nastoupil, Ashish Rai, Joseph Lipscomb, Jessica N Williams, Kevin Ward, David H Howard, Christopher R. Flowers
Publikováno v:
Blood. 122:4401-4401
Background The role of anthracyclines in the management of Grade 3 (G3) FL is unclear. Furthermore, the patterns of care and outcomes of first-line treatment strategies for G3 FL in older adults are not clearly established. We describe the patterns o
Autor:
Loretta J. Nastoupil, Joseph Lipscomb, Chadi Nabhan, Christopher R. Flowers, Kevin C. Ward, David Howard, Ashish Rai, Jessica N. Williams
Publikováno v:
Blood. 122:1817-1817
Background The oldest old constitute a large proportion of the total patient (pt) population with FL. Therapeutic decision making in this group is limited by comorbidities, adverse disease and pts' characteristics, potential treatment toxicity, and l
Autor:
Christopher R. Flowers, David Howard, Ashish Rai, Kevin C. Ward, Loretta J. Nastoupil, Joseph Lipscomb
Publikováno v:
Blood. 122:1805-1805
Background Therapeutic decision making for patients with low-grade (grade 1 and 2) FL involves deciding whether to treat, when to treat, and which among the numerous treatment modalities to administer. The lack of trials comparing outcomes of these t